Brief: Eagle Pharmaceuticals Gets Nasdaq Deficiency Notice On Requirement To Timely File Annual Report On Form 10-K
12/04/2024 21:55
April 12 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS ANNOUNCES RECEIPT OF NOTIFICATION OF
DEFICIENCY FROM NASDAQ REGARDING REQUIREMENT TO TIMELY FILE
ANNUAL REPORT ON FORM 10-K
Source text for Eikon: ID:nGNX1NR3yv
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq